ABL1 and ameloblastoma: The significant difference in VIM3 expression between U‐ABL and DF (p = 0.0384) highlights a potential biomarker for distinguishing between these lesions, aligning with (Qiao et al. 2020) who demonstrated that cytoskeletal dynamics play a crucial role in ameloblastoma cell migration.